Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?

Hered Cancer Clin Pract · 2022 · PMC9006521 · PMID 35418215

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Primary treatment (surgery/neoadjuvant chemotherapy) was added to the multivariable models post-hoc given its highly significant association with multiple MICRA outcomes.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.